🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
LKF
$LKFT
🔒 US EquitiesLakefront Boitherapeutics
AVG HISTORICAL GAP
-0.70%
MAX GAP RECORD
-13.40%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $LKFT
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$LKFT
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 10, 2026 Earnings Release 2026-08-10 (AFTER CLOSE) |
+1.82%
|
| Mar 26, 2026 Earnings Release 2026-03-26 (AFTER CLOSE) |
+0.03%
|
| Nov 05, 2025 Earnings Release 2025-11-05 (AFTER CLOSE) |
+1.74%
|
| Jul 23, 2025 Earnings Release 2025-07-23 (AFTER CLOSE) |
-13.40%
|
| Apr 23, 2025 Earnings Release 2025-04-23 (AFTER CLOSE) |
+0.24%
|
| Feb 12, 2025 Earnings Release 2025-02-12 (AFTER CLOSE) |
-4.12%
|
| Oct 30, 2024 Earnings Release 2024-10-30 (AFTER CLOSE) |
-5.77%
|
| Aug 01, 2024 Earnings Release 2024-08-01 (AFTER CLOSE) |
-1.64%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
3.2%
Bullish Gaps (5)
Bearish Gaps (6)
Neutral / Flat (3)
📖 Intelligence Summary
Lakefront Biotherapeutics is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗